PROPOFOL | N019627 | FRESENIUS KABI USA LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D.N.J. | 2018-03-01 | Terminated 2018-11-28 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from GensiaSicor Pharmaceuticals FDA-2000-P-1219 GensiaSicor Pharmaceuticals filed an ANDA Suitability Petition under Section 505(j)(2)(c) requesting permission to submit an abbreviated new drug application for Propofol Injectable Emulsion 2% in 10 mL and 50 mL single-use vials, which would deliver the same drug amount as the reference listed drug | Other | 2009-10-08 | Denied | GensiaSicor Pharmaceuticals |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.